BONE MARROW FAILURE IN LIGASE IV DEFICIENCY CURED BY ALLOGENEIC HSCT
harbored variants associated with predisposition to malignancies, particularly leukemias.Pediatric patients dominated the cancer-predisposing subgroup, often undergoing molecular evaluation early.These findings underscore the importance of timely genetic testing to guide surveillance and support family counseling, ultimately improving outcomes.
Authors
- Fabian Hauck (ORCID: https://orcid.org/0000-0001-9644-2003)
- Tim Niehues (ORCID: https://orcid.org/0000-0002-9945-8833)
- Sabine Seidel (ORCID: https://orcid.org/0000-0002-1671-3297)
- Cheri E. Klein (ORCID: https://orcid.org/0000-0003-4926-1570)
- Lang JB
- Vallée TC
- Albert MH
Institutions
- Helios Klinikum Krefeld (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- EJC Paediatric Oncology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.ejcped.2025.100377
- Primary Topic
- Mineralogy and Gemology Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00